In February, H1, a healthcare analytics specialist, decided to raise additional capital just months after closing a $100 million Series C at a $750 million valuation, led by Altimeter.
That turned out to be a good call. H1 received commitments from insiders for a $23 million Series C extension—at the same valuation and terms most recently agreed upon. The financing was agreed to shortly before market conditions for tech stocks and pre-IPO companies took a turn for the worse. READ MORE
Street Address
City, State, Zip
770-315-6331
executive compensation - venture capital - news
Your Custom Text Here